|
TFHX Regimen Clinical Trials
1 actively recruiting trial across 1 location
Also known as: paclitaxel, fluorouracil (5-FU), hydroxyurea
Chicago, Illinois1 trial
Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer
University of Chicago Medicine Comprehensive Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.